You are here

Military Safety: A Systems Perspective on Lariam
Peta BathieRUSI Journal, 29 April 2020
UK, Law and Ethics, Military Personnel, Europe
Lariam is an antimalarial drug that has a safety profile characterised by a predominance of neuropsychiatric adverse reactions. It is still prescribed within the British armed forces. A purposive survey (n = 28) of serving and ex-serving British military personnel with experience of operations where Lariam was used revealed that 82% experienced side effects and 85.71% considered the drug unsuitable for use during military operations. An additional online survey (n = 50) provided supporting results. Using system theory analysis, Peta Bathie argues that Lariam use degrades decision-making, damages unit morale and erodes cohesiveness. Because it undermines fighting power, the consumption of such antimalarials appears inconsistent with current UK military doctrine.
Continue Reading
Become A Member
To access the full text of this article and many other benefits, become a RUSI member.
Diversity in the UK's Intelligence Agencies
Financing Right-Wing Extremism and Terrorism
New UK Government Initiative to Support High-Risk, High-Reward Military Science Needs Refinement